Takeda Gets Japan Approval For Five Drugs Pending Price-Setting
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical says Japan's health ministry has approved five of its drugs and its first innovative drugs are to enter the national market in five years